Membrane-based cell culture technologies: a scientifically and economically satisfactory alternative to malignant ascites production for monoclonal antibodies

Res Immunol. 1998 Jul-Aug;149(6):557-9. doi: 10.1016/s0923-2494(98)80006-0.

Author

U Marx¹

Affiliation

¹ University of Leipzig, Institute for Clinical Immunology and Transfusion Medicine, Department of Medical Biotechnology, Germany.

PMID: 9835418
DOI: 10.1016/s0923-2494(98)80006-0

No abstract available

MeSH terms

Animals
Antibodies, Monoclonal / biosynthesis*
Antibodies, Monoclonal / isolation & purification
Ascites / immunology
Cell Culture Techniques / economics*
Cell Culture Techniques / methods*
Costs and Cost Analysis
Hybridomas / immunology*
Hybridomas / physiology
Mice
Perfusion
Rats
Tumor Cells, Cultured

Substances

Antibodies, Monoclonal